Cytotoxic activity of bromodomain inhibitor NVS-CECR2-1 on human cancer cells
Sign Up to like & getrecommendations! Published in 2020 at "Scientific Reports"
DOI: 10.1038/s41598-020-73500-7
Abstract: Bromodomain (BRD), a protein module that recognizes acetylated lysine residues on histones and other proteins, has recently emerged as a promising therapeutic target for human diseases such as cancer. While most of the studies have… read more here.
Keywords: nvs cecr2; cytotoxic activity; cecr2; cancer cells ... See more keywords